Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Charles River Laboratories Intl (CRL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,867,470
  • Shares Outstanding, K 48,226
  • Annual Sales, $ 2,266 M
  • Annual Income, $ 226,370 K
  • 36-Month Beta 0.99
  • Price/Sales 3.03
  • Price/Cash Flow 15.02
  • Price/Book 5.20

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate 1.40
  • Number of Estimates 10
  • High Estimate 1.48
  • Low Estimate 1.32
  • Prior Year 1.38
  • Growth Rate Est. (year over year) +1.45%

Price Performance

See More
Period Period Low Period High Performance
1-Month
116.24 +24.46%
on 01/23/19
145.23 -0.39%
on 02/22/19
+27.08 (+23.03%)
since 01/22/19
3-Month
103.00 +40.46%
on 01/03/19
145.23 -0.39%
on 02/22/19
+19.52 (+15.60%)
since 11/21/18
52-Week
101.58 +42.42%
on 04/06/18
145.23 -0.39%
on 02/22/19
+39.04 (+36.96%)
since 02/22/18

Most Recent Stories

More News
Uptrend Call Working As Charles River La Stock Rises 25.6% (CRL)

SmarTrend identified an Uptrend for Charles River La (NYSE:CRL) on January 8th, 2019 at $115.65. In approximately 2 month, Charles River La has returned 25.56% as of today's recent price of $145.20.

CRL : 144.67 (+1.60%)
Charles River Laboratories (CRL) Q4 Earnings and Revenues Surpass Estimates

Charles River (CRL) delivered earnings and revenue surprises of 7.19% and 1.94%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?

CRL : 144.67 (+1.60%)
Charles River: 4Q Earnings Snapshot

WILMINGTON, Mass. (AP) _ Charles River Laboratories International Inc. (CRL) on Wednesday reported fourth-quarter net income of $59.7 million, after reporting a loss in the same period a year earlier.

CRL : 144.67 (+1.60%)
Charles River Laboratories Announces Fourth-Quarter and Full-Year 2018 Results and Provides 2019 Guidance

--- Fourth-Quarter GAAP Earnings per Share of $1.21 and Non-GAAP Earnings per Share of $1.49 -

CRL : 144.67 (+1.60%)
Charles River Laboratories Signs Binding Offer to Acquire Citoxlab

--- Transaction Expected to be Accretive to Non-GAAP EPS by Approximately $0.15 in 2019 and At Least $0.35 in 2020 -

CRL : 144.67 (+1.60%)
Earnings Preview: Charles River Laboratories (CRL) Q4 Earnings Expected to Decline

Charles River (CRL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CRL : 144.67 (+1.60%)
SmarTrend Watching for Potential Pullback in Shares of Charles River La After 1.00% Gain

Charles River La (NYSE:CRL) traded in a range yesterday that spanned from a low of $128.63 to a high of $129.34. Yesterday, the shares gained 1.0%, which took the trading range above the 3-day high of...

CRL : 144.67 (+1.60%)
Charles River La Set to Possibly Pullback After Yesterday's Rally of 1.55%

Charles River La (NYSE:CRL) traded in a range yesterday that spanned from a low of $123.39 to a high of $125.10. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of...

CRL : 144.67 (+1.60%)
Charles River Laboratories Selected for 2019 Bloomberg Gender-Equality Index

Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it is pleased to have been selected as one of 230 companies for the 2019 Bloomberg Gender-Equality Index (GEI),...

CRL : 144.67 (+1.60%)
Charles River Laboratories and Atomwise Form a Strategic Alliance to Provide Integrated, Artificial Intelligence-Driven Drug Discovery

Charles River Laboratories International, Inc. (NYSE: CRL) and Atomwise, Inc. today announced the formation of a strategic alliance that offers clients access to Atomwise's artificial intelligence...

CRL : 144.67 (+1.60%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators mostly agree with the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade CRL with:

Business Summary

Charles River Laboratories International, Inc. provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Their dedicated employees are focused...

See More

Key Turning Points

2nd Resistance Point 147.23
1st Resistance Point 145.95
Last Price 144.67
1st Support Level 142.67
2nd Support Level 140.67

See More

52-Week High 145.23
Last Price 144.67
Fibonacci 61.8% 128.56
Fibonacci 50% 123.40
Fibonacci 38.2% 118.25
52-Week Low 101.58

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar